Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Haifang
NCT06350890: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes	Active, not recruiting	3	408	RoW	HTD1801, berberine ursodeoxycholate, Placebo	HighTide Biopharma Pty Ltd	T2DM (Type 2 Diabetes Mellitus)	03/25	09/25
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin	Active, not recruiting	3	551	RoW	HTD1801, berberine ursodeoxycholate, Placebo	HighTide Biopharma Pty Ltd	Type 2 Diabetes Mellitus	03/25	12/25
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects	Not yet recruiting	3	408	RoW	TQF3510 (Semaglutide Injection), Wegovy®	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Obesity	07/26	08/26
NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus	Not yet recruiting	2	318	RoW	HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	Type 2 Diabetes	04/25	04/25
Song, Mingai
No trials found